Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2001 Apr;124(1):9-15.
doi: 10.1046/j.1365-2249.2001.01497.x.

Determination of the frequency of HLA antibody secreting B-lymphocytes in alloantigen sensitized individuals

Affiliations
Free PMC article

Determination of the frequency of HLA antibody secreting B-lymphocytes in alloantigen sensitized individuals

A Mulder et al. Clin Exp Immunol. 2001 Apr.
Free PMC article

Abstract

Sera from prospective transplant patients are usually screened for HLA antibodies prior to transplantation, but presently available tests do not permit quantification of the humoral alloantigen directed response. We adapted a culture system for isolated human B-lymphocytes to assay the secretion of HLA-antibodies on a single cell basis. B-cell supernatants were screened for HLA antibodies by complement dependent cytotoxicity. The assay assigns precursor frequencies for HLA-alloantibody secreting B-lymphocytes (BCPFs), and simultaneously allows for dissection of the humoral alloantigen directed response into its monoclonal components. The lymphocytes of 15 HLA-seropositive multiparous women that were used to validate the assay, were found to contain HLA-BCPFs ranging from 0 to 123 per 10(6) B-lymphocytes (mean: 43 +/- 45 per 10(6) B-lymphocytes). The HLA-specificities of antibodies in the B-cell supernatants were in agreement with serum specificities. Genuine HLA reactivity of B-cell supernatants was confirmed using an ELISA with purified HLA class I antigens. When applied to lymphocytes of patients on transplant waiting lists, the present assay may enable the unraveling of serum specificities in their components, thus supplementing HLA antibody serum screening data.

PubMed Disclaimer

References

    1. Patel R, Terasaki PI. Significance of the positive crossmatch test in kidney transplantation. N Engl J Med. 1969;280:735–9. - PubMed
    1. Terasaki PI, Thrasher DL, Hauber TH. Serotyping for homotransplantation. XIII Immediate kidney rejection and associated preformed antibodies. In: Dausset J, Hamburger J, Mathe G, editors. Advances in Transplanatation. Copenhagen: Munksgaard; 1968. pp. 225–9.
    1. Williams GM, Hume DM, Hudson Rp, Jr, Morris PJ, Kano K, Milgrom F. ‘Hyperacute’ renal-homograft rejection in man. N Engl J Med. 1968;279:611–8. - PubMed
    1. Kissmeyer-Nielsen F, Olsen S, Petersen VP, Fjeldborg O. Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells. Lancet. 1966;2:662–5. - PubMed
    1. Smits JM, van Houwelingen HC, De Meester J, Persijn GG, Claas FH. Analysis of the renal transplant waiting list: application of a parametric competing risk method. Transplantation. 1998;66:1146–53. - PubMed

Publication types

MeSH terms